Prescrypto is rolling out digital prescriptions with Doctoralia

Prescrypto is a blockchain startup from Mexico.

Contxto – Last I heard of healthtech startup Prescrypto, it had wrapped up its participation in UNICEF’s Innovation Fund program for blockchain companies. But it’s on the move again and even snagged a partnership with Polish-owned telemedicine platform, Doctoralia.

Consequently, the docs in Mexico who use Doctoralia can now procure digital prescriptions.

Prescrypto and Doctoralia: the perfect partnership?

Almost everyone has a lot to gain from these two companies joining forces. 

Because Prescrypto uses blockchain tech, devious patients and third-parties can’t tamper with it. Besides mitigating drug trafficking and addictions, this solution is also more user-friendly for patients.

“There’s no need to have the prescription at hand. You can just take the QR code that’s generated with the prescription,” explained Adrián Alcántara, COO for Doctoralia in Mexico, Colombia, and Argentina.

“Pharmacies that are equipped for it can then provide the medication.”

Likewise, pharmacists no longer have to deal with interpreting doctors’ crazy handwriting. Thus ensuring that patients get exactly what they need.

Evidently, Doctoralia gains by offering its users (both doctors and patients) a more integral and touchless experiene.

It’s also good news for Prescrypto as it’s cozied up with a partner with over 180,000 registered healthcare professionals and more than 5 million website visitors from Mexico.

The only ones really left out of this happy picture are rural areas whose pharmacies may not be equipped with the right systems to take on digital prescriptions.

Alas, one problem at a time, eh?

A fully digitized experience

Since the Covid-19 outbreak, telemedicine platforms have been popping up across Latam and raising funding. Certainly their chat systems and video conferencing tools have proved useful to more than one user throughout these unusual circumstances (myself included).

But what shall happen when the market becomes saturated and it’s relatively safer for patients to visit their physician? What shall push them to opt for a video call with a cardiologist as opposed to seeing one in person?

I’m one to believe that for routine concerns like follow-up for diabetics or people looking to lose weight, telemedicine in general will continue to be an attractive option. However for more delicate matters, patients will feel more comfortable with face-to-face consultations.

The telemedicine platforms that can offer more integral solutions (e.g. offering digital prescriptions or letting patients book an in-person appointment) should fare better than those that settle for just videoconferencing or online chats. 

That’s my diagnosis and I’m sticking to it (for now).

Related articles: Tech and startups from Mexico!

-ML

Scaling a startup or scouting for your next deal?
We help you get there faster.